Wei Hua

机构：Central South University, Peking University, Northern Jiangsu People's Hospital, Xiangya Hospital Central South University · ORCID：0000-0003-4014-989X

发表论文 419 篇 · 总被引 6337 次 · h-index 34

代表论文

• Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial (2025 · Annals of the Rheumatic Diseases · 被引 22)
• Rapid Initiation of Antiretroviral Therapy With Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Versus Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate in HIV–Positive Men Who Have Sex With Men in China: Week 48 Results of the Multicenter, Randomized Clinical Trial (2024 · Clinical Infectious Diseases · 被引 19)
• CMR feature tracking–based left atrial mechanics predicts response to cardiac resynchronization therapy and adverse outcomes (2024 · Heart Rhythm · 被引 5)
• Triple-combination therapy did not improve prognosis in anti-MDA5 positive dermatomyositis: a multicentre longitudinal cohort study (2024 · Clinical and Experimental Rheumatology · 被引 4)
• Effect and Safety of Herbal Medicine Foot Baths in Patients with Diabetic Peripheral Neuropathy: A Multicenter Double-Blind Randomized Controlled Trial (2024 · Chinese Journal of Integrative Medicine · 被引 4)
• Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial (2025 · Arthritis & Rheumatology · 被引 3)